Life Science ApS: Financial statements 2025
CVR: 38453726
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Life Science ApS (CVR 38453726) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -11,459 and a net result of DKK -11,456 compared with DKK -822 the year before. Equity in the 2025 report amounted to DKK 151,200. The solvency ratio was 32.8%.
- Revenue
- DKK 0
- Gross Profit
- DKK -11,459
- Profit/Loss
- DKK -11,456
- Equity
- DKK 151,200
- Total Assets
- DKK 460,498
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 0 | -11 t. | -11 t. | 151 t. | 0 |
| 2024 | - | -824 | -822 | 14 t. | - |
| 2023 | - | -245 | -245 | 15 t. | - |
| 2022 | - | -733 | -744 | 15 t. | - |
| 2021 | - | -2 t. | -2 t. | 16 t. | - |
Official annual report
How creditworthy is Life Science ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of November 3, 2025, Andreas Kjær is registered as director of Life Science ApS.
As of November 3, 2025, Morten Albrechtsen is registered as director of Life Science ApS.
As of November 3, 2025, Andreas Kjær is registered as an owner of Life Science ApS with an ownership share of 50%.
As of November 3, 2025, WEXOTEC ApS is registered as an owner of Life Science ApS with an ownership share of 33%.
As of November 2, 2025, Andreas Kjær has stepped down as adm. dir. of Life Science ApS.
As of October 27, 2025, inforevision statsautoriseret revisionsaktieselskab has been appointed auditor of Life Science ApS.
Life Science ApS has published its annual report for 2024. Gross profit came to DKK -824, and the net result was DKK -822.
About Life Science ApS
Life Science ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Life Science IVS and FluoGuide IVS. The management consists of Andreas Kjær and Morten Albrechtsen. The company is owned by Andreas Kjær and WEXOTEC ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,459 and a net result of DKK -11,456 compared with DKK -822 the year before. Equity in the 2025 report amounted to DKK 151,200.